Modeling the effects of omalizumab over 5 years among patients with moderate-to-severe persistent allergic asthma

By Grossman H.L.   Schlender Amory   Alperin Peter   Stanley Elizabeth L.   Zhang Jie  

Current Medical Research and Opinion, Vol. 26, Iss. 12, 2010-12 ,pp. : 2779-2793

Informa Healthcare

Access to resources Recommend Favorite

Improvement in quality of life with omalizumab in patients with severe allergic asthma

By Chipps Bradley   Buhl Roland   Beeh Kai-Michael   Fox Howard   Thomas Karen   Reisner Colin  

Current Medical Research and Opinion, Vol. 22, Iss. 11, 2006-11 ,pp. : 2201-2208

Informa Healthcare

Access to resources Recommend Favorite

Omalizumab could be effective in children with severe eosinophilic non‐allergic asthma

By  

PEDIATRIC ALLERGY AND IMMUNOLOGY, Vol. 29, Iss. 1, 2018-02 ,pp. : 90-93

John Wiley & Sons Inc

Access to resources Recommend Favorite

Oral corticosteroid sparing with omalizumab in severe allergic (IgE-mediated) asthma patients

By Siergiejko Zenon   ŚŚwiebocka Ewa   Smith Nicola   Peckitt Clare   Leo Jo   Peachey Guy   Maykut Robert  

Current Medical Research and Opinion, Vol. 27, Iss. 11, 2011-11 ,pp. : 2223-2228

Informa Healthcare

Access to resources Recommend Favorite

Anti-IgE Therapy with Omalizumab Decreases Endothelin-1 in Exhaled Breath Condensate of Patients with Severe Persistent Allergic Asthma

By  

Respiration, Vol. 80, Iss. 6, 2010-06 ,pp. : 534-542

Karger

Access to resources Recommend Favorite